Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.

Pountney DL, Raftery MJ, Chegini F, Blumbergs PC, Gai WP.

Acta Neuropathol. 2008 Dec;116(6):603-14. doi: 10.1007/s00401-008-0437-4. Epub 2008 Oct 3.

PMID:
18836734
2.

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.

Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, Blumbergs PC, Gai WP.

Exp Neurol. 2003 Nov;184(1):436-46.

PMID:
14637113
3.

Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

McFadden K, Hamilton RL, Insalaco SJ, Lavine L, Al-Mateen M, Wang G, Wiley CA.

J Neuropathol Exp Neurol. 2005 Jun;64(6):545-52.

4.

Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.

Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M, Watanabe H, Sobue G.

Neurology. 2011 Apr 19;76(16):1372-6. doi: 10.1212/WNL.0b013e3182166e13. Epub 2011 Mar 16.

PMID:
21411744
5.

Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.

Mori F, Tanji K, Odagiri S, Hattori M, Hoshikawa Y, Kono C, Yasui K, Yokoi S, Hasegawa Y, Kamitani T, Yoshida M, Wakabayashi K.

Pathol Int. 2012 Jun;62(6):407-11. doi: 10.1111/j.1440-1827.2012.02812.x. Epub 2012 Mar 16.

PMID:
22612509
6.

The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains.

Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT.

Neurobiol Dis. 2006 Jan;21(1):181-93. Epub 2005 Aug 24.

PMID:
16125395
7.

Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.

Liu Y, Mimuro M, Yoshida M, Hashizume Y, Niwa H, Miyao S, Ujihira N, Akatsu H.

Acta Neuropathol. 2008 Dec;116(6):615-23. doi: 10.1007/s00401-008-0442-7. Epub 2008 Oct 16.

PMID:
18923837
8.

SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.

Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H.

Neuroreport. 2002 Dec 3;13(17):2359-64.

PMID:
12488827
9.

SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.

Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP.

Neurosci Lett. 2005 Jun 10-17;381(1-2):74-9. Epub 2005 Mar 2.

PMID:
15882793
10.

FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.

Mori F, Tanji K, Kon T, Odagiri S, Hattori M, Hoshikawa Y, Kono C, Yasui K, Yokoi S, Hasegawa Y, Yoshida M, Wakabayashi K.

Neuropathol Appl Neurobiol. 2012 Jun;38(4):322-8. doi: 10.1111/j.1365-2990.2011.01217.x.

PMID:
21883376
11.

Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.

Wiltshire KM, Dunham C, Reid S, Auer RN, Suchowersky O.

Can J Neurol Sci. 2010 Mar;37(2):213-8.

PMID:
20437931
12.

Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.

Umahara T, Uchihara T, Yagishita S, Nakamura A, Tsuchiya K, Iwamoto T.

Neurosci Lett. 2007 Mar 6;414(2):130-5. Epub 2006 Dec 27.

PMID:
17224237
13.

Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.

Woulfe JM.

Neuropathol Appl Neurobiol. 2007 Feb;33(1):2-42. Review.

PMID:
17239006
14.

Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.

Mackenzie IR, Butland SL, Devon RS, Dwosh E, Feldman H, Lindholm C, Neal SJ, Ouellette BF, Leavitt BR.

BMC Neurol. 2006 Aug 31;6:32.

15.

FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.

Woulfe J, Gray DA, Mackenzie IR.

Brain Pathol. 2010 May;20(3):589-97. doi: 10.1111/j.1750-3639.2009.00337.x. Epub 2009 Sep 21.

PMID:
19832837
16.

Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.

Uchihara T, Tanaka J, Funata N, Arai K, Hattori T.

Acta Neuropathol. 2003 Feb;105(2):103-8. Epub 2002 Sep 13.

PMID:
12536220
17.

Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.

Mori F, Tanji K, Toyoshima Y, Sasaki H, Yoshida M, Kakita A, Takahashi H, Wakabayashi K.

Neuropathology. 2013 Dec;33(6):637-44. doi: 10.1111/neup.12050. Epub 2013 Jun 19.

PMID:
23782134
18.

Neuronal intranuclear hyaline inclusion disease.

Takahashi-Fujigasaki J.

Neuropathology. 2003 Dec;23(4):351-9. Review.

PMID:
14719553
19.

Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions.

Schmidt T, Lindenberg KS, Krebs A, Schöls L, Laccone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer GB.

Ann Neurol. 2002 Mar;51(3):302-10.

PMID:
11891825
20.

Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy.

Lin WL, DeLucia MW, Dickson DW.

Neurosci Lett. 2004 Jan 9;354(2):99-102.

PMID:
14698448

Supplemental Content

Support Center